{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihpshum3txjgyvhjrbkubk5a452ynhcavr5nz3d5glnh35wiba2wa",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mg6wyji3h5t2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigvtcmdlgnvt3yvors77lkag4m33tlx353thhuc5aj27flgwc6k7m"
    },
    "mimeType": "image/jpeg",
    "size": 58406
  },
  "path": "/2026/03/03/prime-medicine-seeks-fda-approval-cgd-disease-gene-editing-treatment/?utm_campaign=rss",
  "publishedAt": "2026-03-03T17:39:53.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "In the Lab",
    "Pharma",
    "biotechnology",
    "CRISPR",
    "drug development",
    "FDA",
    "STAT+"
  ],
  "textContent": "Prime Medicine's application will test an FDA that has promised to speed new gene-editing treatments but has recently spurned some.",
  "title": "STAT+: Prime Medicine to seek approval for gene-editing treatment after two-patient trial",
  "updatedAt": "2026-03-03T19:25:59.000Z"
}